Pure Insight Executive Membership - Best Practice Visit Outline
Company
AstraZeneca
Topic(s)
R&D Portfolio Management & Business Performance Management
(specific focus on Development rather than Discovery)
Date and
Location
November 11, 2008
Alderley Park, Macclesfield, Cheshire
Visit leader
Speaker 1: Dr Mellor Hennessy (Global Portfolio Strategist)
Speaker 2: David Scanlon (Business Manager)
Company/
Presentation
background
Mellor Hennessy was part of the Portfolio integration task force when Astra
and Zeneca merged in 1999. Since then he has been a member of the cross
functional team running the Portfolio process and making incremental
improvements at each annual review. Recently he has taken on leadership of the
R&D Performance Network – cascading the R&D scorecard throughout the
organisation. His professional interest is innovation in management practice.
AstraZeneca is a global Pharmaceutical company with an R&D organisation of
13,000 people and annual budget of $3-4B. A stage/gate process is at the heart
of Pharmaceutical R&D and the Development organisation at AstraZeneca is
currently focused on establishing a project management and continuous
improvement culture. Performance metrics throughout R&D are pipeline
progressions, time, unit cost, and value.
Mellor and David will describe the evolution of both Portfolio Management and
Business Performance Management at AstraZeneca, explaining what innovations
in practice have worked well and why. They will also share learning from some
of the failures, and describe future ambitions.
As well as the presentations, the visit will include:




Recommended
for
30 minute tour of Alderley Park Country Estate
60 minutes of Q&A: An opportunity to dig deeper with the
AstraZeneca team
45 minutes of Roundtable Discussions: Addressing participants’ most
pressing challenges
90 minutes Open Networking sessions: Meet and develop relationships
with other Executive and Group members
Anyone interested in understanding what generates significant and lasting
change in an organisation; how to manage product portfolios and business
performance in large and complex environments; and what works and what
doesn’t when integrating, teams, processes and companies.
Draft itinerary
10.00 – 10.15 Introductions and welcome
10.15 – 10.30 Mellor Hennessy - Pharma, R&D and AstraZeneca
The pharma stage/gate process
Industry and AstraZeneca dimensions
The merger of Astra and Zeneca, and evolution to date
10.30 – 11.15 Mellor Hennessy - R&D Business Performance
Management
Cascade of objectives to 12,000 people in R&D
Managing performance of 20 organisation units within R&D
Using performance management process to drive portfolio
objectives
Factors determining success over past 10 years
Does it really work?
11.15 – 11.45 Coffee, networking break
11.45 – 12.30 David Scanlon - Project and Portfolio Management
Merging Astra & Zeneca to create one portfolio & one process
Evolving the portfolio process over the past decade - what has
changed and why
Integrating project and portfolio management
The future - integrated systems and behaviour change - will it
work?
12.30 – 13.30 Networking lunch
13.30 – 14.00 Q&A session with AstraZeneca team
14.00 – 14.30 Tour of Alderley Park Country Estate
14.30 – 15.15 Roundtable discussions
Additional
information
For those arriving the night before the visit, The Alderley Edge hotel is situated
10 minutes drive from the AstraZeneca site (www.alderleyedgehotel.com)